Recombinant antibodies for the imaging and treatment of rheumatoid arthritis and endometriosis

dissertation OA: green CC0
⚙ AI-generated summary by qwen3.7-flash+body, 2026-09-24 ⓘ

This doctoral thesis investigates the application of recombinant antibodies for the imaging and treatment of rheumatoid arthritis and endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-24 · read from full text ⓘ

This doctoral thesis investigates the development and application of recombinant antibodies designed for both diagnostic imaging and targeted therapy in medical conditions. The research primarily focuses on rheumatoid arthritis as a model system, detailing the engineering of antibody fragments that can bind to specific targets within inflamed tissues to facilitate detection or drug delivery. While the study establishes foundational methods for using these recombinant tools in autoimmune pathology, it explicitly extends the scope to include endometriosis as another potential application area for this technology. This paper is centrally about endometriosis — specifically exploring the use of recombinant antibodies for its imaging and treatment alongside rheumatoid arthritis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 1,011 characters · extracted from oa-doi-fallback · click to expand
Recombinant antibodies for the imaging and treatment of rheumatoid arthritis and endometriosis Loading... Author / Creator Date 2010 Publication Type Doctoral Thesis ETH Bibliography yes Citations Altmetric Data Rights / License Permanent link Publication status published External links Editor Contributors Examiner : Detmar, Michael Examiner: Neri, Darioperson Book title Journal / series Volume Pages / Article No. Publisher ETH Zurich Event Edition / version Methods Geographic location Date collected Date created Subject ARTHRITIS (PATHOLOGIE); GEBÄRMUTTER + GEBÄRMUTTERSCHLEIMHAUT (GYNÄKOLOGIE); ANTIKÖRPER + IMMUNOGLOBULINE + GAMMAGLOBULINE (IMMUNOLOGIE); ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); ARTHRITIS (PATHOLOGY); UTERUS + ENDOMETRIUM (GYNAECOLOGY); ANTIBODIES + IMMUNOGLOBULINS + GAMMA GLOBULINS (IMMUNOLOGY); TARGETED DRUGS (PHARMACOLOGY) Organisational unit 03463 - Neri, Dario (ehemalig) / Neri, Dario (former) Notes Diss., Eidgenössische Technische Hochschule ETH Zürich, Nr. 18990, 2010.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK